Frost & Sullivan awards Lingkai Technology the 'China Small Molecule Compound Innovation Award'

Frost & Sullivan awards Lingkai Technology the 'China Small Molecule Compound Innovation Award'

Published: 2025/08/29

沙利文授予凌凯科技「中国小分子化合物创新奖」

Shanghai Lingkai Technology Co., Ltd.

"China Small Molecule Compound Innovation Award"

On the evening of August 27, the 2025 Frost & Sullivan Global Growth, Innovation and Leadership Awards for China and Best Practices were grandly announced at the 2025 Frost & Sullivan Global Growth, Innovation and Leadership Awards Ceremony and VIP Reception.

 

Based on the research and analysis of the new functional materials market in recent years, as well as the study and evaluation of related companies in the industry, Frost & Sullivan has awarded the 'China Small Molecule Compound Innovation Award' to Shanghai Lingkai Technology Co., Ltd. (hereinafter referred to as 'Lingkai Technology'). Wang Chenhui, Managing Partner and President of Frost & Sullivan Greater China, and Manoj Menon, Founder and CEO of Twimbit and an expert advisor to the Global Expert Advisory Group of Frost & Sullivan, presented the award to Dr. Wang Haiming, Chief Scientist of Shanghai Lingkai Technology Co., Ltd.

Wang Chenhui, Partner-in-Chief and President of Frost & Sullivan Greater China, and Manoj Menon, Founder and CEO of Twimbit and a member of the Frost & Sullivan Global Expert Advisory Group, presented awards to Dr. Wang Haiming, Chief Scientist of Shanghai Lingkai Technology Co., Ltd.

 

Lingkai Technology is a pioneer in 'Flow Chemistry and Green Catalysis' in China, dedicated to the modern development of synthetic chemistry and fluid engineering.

Lingkai Technology was established in 2011, focusing on the research and development of technology applications in organic synthesis chemistry and fluid engineering technology. It mainly provides R&D, production, and commercialization solutions for small molecule compounds. Lingkai Technology's business spans and deeply penetrates three major fields: pharmaceuticals, new materials, and new energy. By driving innovation with engineering processes in coordination, it achieves rapid response to diverse customer needs, accelerates the implementation of product services, and helps customers improve overall economic benefits. Lingkai Technology has profound R&D strength and industrial transformation capabilities, owning a R&D and operation center of over 8,600 square meters. Relying on an experienced and powerful core R&D team, it has built a one-stop biopharmaceutical CDMO platform; it adheres to implementing a technology innovation-driven strategy, independently developing two core technology platforms, 'Flow Chemistry and Microchannels' and 'Green Catalysis', to promote process innovation and industrial upgrading. Lingkai Technology owns two commercial production factories, concentrating on developing new quality productivity, achieving large-scale, intelligent, and efficient production.

 

Lingkai Technology has customers across five continents and collaborates with over 5,000 partners to build a greener future.

As an innovative enterprise in the field of new materials in China, Lingkai Technology maintains a competitive edge in niche markets through independent research and development and technological accumulation. It always adheres to the concept of green, low-carbon, and sustainable development, promoting the long-term vitality of the enterprise and industry. Lingkai Technology's core products have been widely applied in strategic emerging industries such as medicine, new materials, and new energy, serving many well-known domestic and international enterprises. Lingkai Technology insists on empowering customers with technology and repaying society with responsibility, continuously promoting energy conservation, emission reduction, recycling, and green intelligent manufacturing practices, providing high-performance solutions for customers, actively exploring a green future, and upholding the core concept of "technology empowering sustainability," achieving symbiosis and prosperity between brand vitality and environmental vitality. Lingkai Technology's business has covered the five continents of the world, adhering to the development philosophy of "science, rigor, innovation, cooperation," based in China and radiating globally, committed to becoming an important partner in the fields of medicine, new materials, and new energy that customers around the world trust, and continuously contributing to life health and green energy endeavors.

 

Lingkai Technology has won numerous industry honors, demonstrating its innovation capabilities and industrial leadership.

In 2024, Lingkai Technology performed outstandingly in the industry. It won the 'Product Power Award' at the 'New Display Technology and Supply Chain Industry Annual Conference' hosted by TrendBank, highlighting its product competitiveness and technical quality. After a rigorous selection by the Organizing Committee of the China Brand Summit from multiple aspects such as comprehensive strength, service level, and brand building, Lingkai Technology was awarded the 'Top Ten Innovative Brands of 2024 (Industry)' award. In 2024, Lingkai Technology applied for a total of 50 new patents (38 domestic invention patents, 3 domestic utility model patents, 3 domestic design patents, and 6 international PCT patents), and authorized 14 (12 domestic invention patents and 2 domestic utility model patents), further consolidating its leading position in the fields of new materials and chemical synthesis. Lingkai Technology continues to focus on R&D-driven development and standardization construction, adhering to the equal importance of innovation and responsibility. It collaborates with upstream and downstream industries to jointly promote the high-quality development and globalization process of China's new material industry.

 

About the Frost & Sullivan China Innovation Award

The Frost & Sullivan China Innovation Award recognizes outstanding performance and achievements in technological innovation, market potential, customer service, brand, and other aspects by enterprises. The Frost & Sullivan team nominated a competitive group of excellent companies to the independent judging panel through methods such as in-depth interviews, industry analysis, and secondary research. An independent judging panel composed of third-party investment and financing experts, financial experts, bankers, and renowned listed entrepreneurs conducted a rigorous review of the companies nominated by the Frost & Sullivan team and decided to award the 'China Small Molecule Compound Innovation Award' to Shanghai Lingkai Technology Co., Ltd.

* 以上内容系沙利文研究团队基于市场研究得出,系团队研究成果的公示,研究所使用的部分信息来源于公开资料。如您对本次研究的结果有疑义,欢迎发送邮件至: 咨询。


获取白皮书

沙利文授予凌凯科技「中国小分子化合物创新奖」

×
请选择职位类别
请选择
×
联系我们
联系我们
电话

业务咨询热线

(021)54075836

微信
二维码

扫码关注官方微信公众号

返回顶部
返回顶部

联系我们

×
请选择职位类别
请选择
×